Growing community of inventors

Seongnam-si, South Korea

Beom Seon Suh

Average Co-Inventor Count = 16.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Beom Seon SuhSung Yun Cho (1 patent)Beom Seon SuhHyun Jin Kim (1 patent)Beom Seon SuhJong Yeon Hwang (1 patent)Beom Seon SuhJae Du Ha (1 patent)Beom Seon SuhChi Hoon Park (1 patent)Beom Seon SuhPil Ho Kim (1 patent)Beom Seon SuhSong Hee Lee (1 patent)Beom Seon SuhJi Youn Park (1 patent)Beom Seon SuhJe Ho Ryu (1 patent)Beom Seon SuhHo Hyun Lee (1 patent)Beom Seon SuhJung Min Ahn (1 patent)Beom Seon SuhYe Seul Lim (1 patent)Beom Seon SuhHee Jung Moon (1 patent)Beom Seon SuhSun Mi Yoo (1 patent)Beom Seon SuhHan Wool Kim (1 patent)Beom Seon SuhBeom Seon Suh (1 patent)Sung Yun ChoSung Yun Cho (14 patents)Hyun Jin KimHyun Jin Kim (12 patents)Jong Yeon HwangJong Yeon Hwang (10 patents)Jae Du HaJae Du Ha (10 patents)Chi Hoon ParkChi Hoon Park (9 patents)Pil Ho KimPil Ho Kim (5 patents)Song Hee LeeSong Hee Lee (3 patents)Ji Youn ParkJi Youn Park (2 patents)Je Ho RyuJe Ho Ryu (2 patents)Ho Hyun LeeHo Hyun Lee (2 patents)Jung Min AhnJung Min Ahn (2 patents)Ye Seul LimYe Seul Lim (1 patent)Hee Jung MoonHee Jung Moon (1 patent)Sun Mi YooSun Mi Yoo (1 patent)Han Wool KimHan Wool Kim (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Korea Research Institute of Chemical Technology (1 from 624 patents)

2. Ubix Therapeutics, Inc. (1 from 2 patents)


1 patent:

1. 12161722 - Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/31/2025
Loading…